13F Holdings
中文EN

HQY HEALTHEQUITY, INC.

Services-Business Services, NEC · Nasdaq · SEC CIK 1428336 · Fiscal year ends 01/31

Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.3%
TTM net income YoY62.2%
TTM EPS YoY67.9%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR164.2%

Margins

Gross margin71.2%
Operating margin25.8%
Net margin17.4%
FCF margin35.8%
EBITDA margin31.5%

Returns

ROE11.4%
ROA7.1%
ROIC (approx.)9.8%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets39.2%
Debt / equity0.47x
Current ratio2.99x
Interest coverage6.69x

Cash quality & payout

Operating cash flow / net income2.07x
Accruals ratio-7.6%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-01-31FY20252025-01-31FY20242024-01-31FY20232023-01-31FY20222022-01-31
Income statement
Revenue$1.31B$1.20B$999.59M$861.75M$756.56M
Cost of revenue$400.31M$422.51M$376.95M$369.81M$331.79M
Gross profit$913.12M$777.26M$622.64M$491.94M$424.76M
R&D expense$262.51M$239.51M$218.81M$193.38M$157.36M
SG&A expense$119.93M$132.26M$103.66M$97.47M$85.44M
Operating income$322.46M$162.33M$117.70M$9.06M-$24.24M
Interest expense$57.13M$60.63M$55.45M$48.42M$36.57M
Pretax income$277.43M$116.03M$75.04M-$38.10M-$66.74M
Income tax$62.23M$19.33M$19.33M-$11.95M-$22.45M
Net income$215.20M$96.70M$55.71M-$26.14M-$44.29M
EBITDA$477.11M$324.79M$270.78M$170.26M$112.95M
EPS (basic)2.501.110.65-0.31-0.53
EPS (diluted)2.461.090.64-0.31-0.53
Weighted avg. shares (diluted)87.47M88.83M86.96M84.44M83.13M
Balance sheet
Cash & equivalents$318.93M$295.95M$403.98M$254.27M$225.41M
Receivables$123.70M$118.01M$104.89M$96.83M$87.43M
Current assets$512.28M$477.75M$557.44M$382.89M$351.34M
PP&E, net$3.18M$3.24M$6.01M$12.86M$23.37M
Goodwill$1.65B$1.65B$1.65B$1.65B$1.65B
Intangibles$1.10B$1.20B$835.95M$936.36M$973.14M
Total assets$3.38B$3.45B$3.16B$3.09B$3.11B
Current liabilities$156.85M$156.32M$117.09M$131.06M$153.19M
Short-term debt$0$0$0$17.50M$8.75M
Long-term debt$957.38M$1.06B$874.97M$907.84M$922.08M
Total debt$957.38M$1.06B$874.97M$925.34M$930.83M
Total liabilities$1.27B$1.33B$1.13B$1.19B$1.25B
Shareholders' equity$2.11B$2.11B$2.04B$1.90B$1.85B
Net debt$638.45M$760.35M$470.99M$671.07M$705.41M
Shares outstanding85.01M86.54M86.13M84.76M83.78M
Cash flow statement
Operating cash flow$457.09M$339.86M$242.83M$150.65M$141.00M
Capital expenditure$1.97M$2.08M$1.69M$3.37M$8.91M
Free cash flow$455.12M$337.77M$241.13M$147.28M$132.09M
Investing cash flow-$47.14M-$505.45M-$46.07M-$119.13M-$639.25M
Financing cash flow-$386.98M$57.57M-$47.04M-$2.67M$394.86M
Depreciation & amortization$154.66M$162.45M$153.08M$161.20M$137.19M
Stock-based compensation$73.06M$96.42M$77.15M$62.61M$52.75M
Share buybacks$299.25M$121.49M$0$0—

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.